Journey Medical Corp

Healthcare · Drug Manufacturers - Specialty & Generic

6.00$ +0.0% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

Journey Medical Corp (DERM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 98 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DERM
Line item	Q2 16	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	307	312	313	456	708	674	561	506	487	410	344	462	447	436	–	–	–	52	–	73	89	97	121	113	108	105	96	70	66	77	67	65	64	80	85	81	85	95	92	98
Current Assets	303	274	284	433	699	671	557	502	447	393	335	443	428	413	4.8	–	–	35	8.2	53	67	84	90	84	80	78	61	48	45	56	47	46	46	48	54	51	56	67	65	73
Cash	211	56	42	202	418	394	296	289	176	145	105	202	103	75	-4.8	–	–	8.2	8.2	12	22	49	41	38	35	32	17	8.2	25	27	24	24	22	20	21	20	25	24	27	26
Cash & Short-Term Investments	298	332	312	634	1,113	1,055	551	496	437	379	313	388	325	358	4.8	–	–	8.2	8.2	12	22	49	41	38	35	32	17	8.2	25	27	24	24	22	20	21	20	25	24	27	26
Receivables	–	25	21	11	–	–	0.1	0.1	0.1	2.1	5.7	8.5	60	11	–	–	–	24	–	26	32	23	31	29	29	28	28	17	8.0	15	9.8	10	11	10	18	16	18	30	25	36
Inventory	–	–	–	–	–	–	–	–	0.1	2.9	8.4	13	18	24	–	–	–	1.4	–	14	12	9.9	16	16	15	14	13	12	11	10	11	9.7	12	14	12	13	12	9.6	9.3	8.2
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.1	0.1	0.1	0.1	0.0	0.0	0.2	–	0.1	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	1.1	1.1	1.1	1.1	1.1	1.1	1.1	–	1.0	1.0	1.0	0.9	0.9	0.9	–	–	–	15	–	14	13	13	30	29	28	27	26	22	21	20	19	19	18	32	31	30	29	28	26	26
Total Liabilities	36	61	65	51	335	476	411	378	375	356	353	387	382	422	-2.8	–	–	42	-10	74	101	55	79	79	82	88	88	70	49	56	54	54	53	60	63	62	59	63	61	66
Current Liabilities	25	29	35	21	29	143	105	97	94	74	39	62	51	59	–	–	–	28	–	44	60	52	61	60	61	67	77	68	49	42	39	34	33	35	40	40	40	37	38	46
Short-Term Debt	–	–	3.0	–	–	–	4.6	–	–	–	–	4.2	4.2	4.3	–	–	–	4.6	–	0.1	4.5	5.4	2.6	2.7	4.2	3.0	15	12	3.1	3.1	3.1	3.1	1.3	0.7	2.0	3.8	5.7	0.1	2.6	5.1
Accounts Payable	8.8	6.2	14	5.4	8.5	9.7	15	11	12	13	16	6.1	12	11	–	–	–	2.0	–	4.6	29	23	27	33	34	37	44	32	29	16	14	15	15	16	14	13	12	8.9	8.7	8.0
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	5.2	–	5.2	15	–	15	15	20	20	9.9	–	–	15	15	20	20	25	23	21	20	25	23	20
Shareholders' Equity	271	251	247	405	372	199	150	128	112	54	-9.0	75	66	14	2.8	–	–	10	10	-0.8	-12	42	41	35	26	17	7.5	0.0	17	20	13	11	11	20	22	19	26	32	31	32
Retained Earnings	-217	-243	-250	-280	-318	-497	-553	-583	-607	-673	-745	-810	-828	-885	–	–	–	5.1	–	-6.5	-17	-39	-40	-48	-58	-69	-79	-87	-70	-72	-83	-86	-89	-87	-91	-95	-97	-98	-101	-101
Shares Outstanding	31	32	33	37	51	51	51	51	51	42	42	44	54	54	11	16	9.2	16	9.2	9.2	9.2	13	17	17	18	18	18	18	21	19	20	20	21	22	23	23	25	24	27	27

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings